Variant report
Variant | esv3379763 |
---|---|
Chromosome Location | chr20:53464970-53467518 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:53467255..53472616-chr20:53474478..53478474,4 | MCF-7 | breast: | |
2 | chr20:53319613..53321737-chr20:53464141..53465830,2 | MCF-7 | breast: | |
3 | chr17:59939806..59941342-chr20:53462560..53465065,2 | MCF-7 | breast: | |
4 | chr20:53465234..53466924-chr20:53468831..53471072,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000252089 | chromatin interactions |
ENSG00000136492 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192949179 | chr20:53465027-53465028 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs115595436 | chr20:53465030-53465031 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs576291996 | chr20:53465034-53465035 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs145883798 | chr20:53465802-53465803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575249260 | chr20:53465822-53465823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs180807846 | chr20:53465870-53465871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556839760 | chr20:53465891-53465892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573837873 | chr20:53465916-53465917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs78879634 | chr20:53465922-53465923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113569199 | chr20:53465941-53465942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559479337 | chr20:53465948-53465949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572888503 | chr20:53465955-53465956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577192631 | chr20:53465967-53465968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs11697764 | chr20:53465976-53465977 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs564946344 | chr20:53465980-53465981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183802685 | chr20:53466007-53466008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs5842022 | chr20:53466029-53466030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112847039 | chr20:53466031-53466032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs5842023 | chr20:53466040-53466041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs5842024 | chr20:53466048-53466049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs5842025 | chr20:53466058-53466059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs5842026 | chr20:53466062-53466063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs397978542 | chr20:53466067-53466068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs5842027 | chr20:53466072-53466073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs397978543 | chr20:53466074-53466075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs5842028 | chr20:53466078-53466079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs77380032 | chr20:53466079-53466080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530526605 | chr20:53466080-53466081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs5842029 | chr20:53466088-53466089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs5842030 | chr20:53466094-53466095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs34712433 | chr20:53466095-53466096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs5842031 | chr20:53466104-53466105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs386815273 | chr20:53466105-53466106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs5842032 | chr20:53466110-53466111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs397978539 | chr20:53466111-53466112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550557877 | chr20:53466115-53466116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs5842033 | chr20:53466120-53466121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs397978540 | chr20:53466121-53466122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561468230 | chr20:53466128-53466129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368900082 | chr20:53466141-53466142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs59576624 | chr20:53466142-53466143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs397978541 | chr20:53466143-53466144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs111359122 | chr20:53466150-53466151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs59926199 | chr20:53466153-53466154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs397708319 | chr20:53466154-53466155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs3044998 | chr20:53466202-53466203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs386394052 | chr20:53466203-53466204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs386394053 | chr20:53466204-53466205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs397745927 | chr20:53466205-53466206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9753658 | chr20:53466234-53466235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 21693616 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
colon cancer | 17210682 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 21264507 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastric cancer | 17167181 | CNVD |
Myeloproliferative neoplasm | 19047681 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Gastric cancer | 20585902 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Cancer | 21129771 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Lung cancer | 16740712 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16620391 | CNVD |
Okamoto syndrome | 17623483 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Cervical cancer | 16585170 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20459607 | CNVD |
Gastric cancer | 18160780 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Melanoma | 17363583 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:53465800-53467000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr20:53466400-53467400 | Enhancers | Brain Germinal Matrix | brain |
3 | chr20:53466600-53467000 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr20:53467000-53467400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr20:53467000-53467400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr20:53467400-53467600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr20:53467400-53468400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |